Why the study?
Does piperacillin affect blood coagulation and platelet function in healthy volunteers?
Does piperacillin affect blood coagulation and platelet function in healthy volunteers?
Piperacillin induces mild platelet dysfunction and occasional bleeding time prolongation in healthy volunteers, though potentially less severe than related penicillins.
May warrant platelet monitoring with piperacillin; leaves open bleeding risk in patients and requires confirmation beyond healthy volunteers.
Piperacillin is a new semisynthetic penicillin which is similar in structure to carbenicillin and ticarcillin. Since the latter antibiotics have been shown to cause abnormalities in hemostasis, we studied the effects of piperacillin on blood coagulation and platelet function. Fifteen healthy volunteers received the drug in doses of either 100, 200, or 300 mg/kg per day for a period of 7 days. Serial studies showed no abnormalities in blood coagulation in any subject. Decreased platelet aggregation responses to adenosine diphosphate, epinephrine, collagen, and achidonic acid were commonly noted, but prolongation of the bleeding time occurred in only 3 of 15 subjects after 7 days of piperacillin administration. These results suggest that although piperacillin also induces platelet dysfunction, these effects may be less than those caused by ticarcillin or carbenicillin at an equivalent dosage.
No takes yet. Share an insight, caveat, or question.
Gentry et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: